Preterm birth rates in a prematurity prevention clinic after adoption of progestin prophylaxis

Obstetrics and Gynecology

Volumn 123, Issue 1, 2014, Pages 34-39

  Markham, Kara B ^a   Walker, Hetty ^a   Lynch, Courtney D ^a   Iams, Jay D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN;

ADOPTION; ALGORITHM; ARTICLE; CERCLAGE; COHORT ANALYSIS; FEMALE; GESTATIONAL AGE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; PROPHYLAXIS; RACE; RETROSPECTIVE STUDY; SMOKING;

FEMALE; HUMANS; HYDROXYPROGESTERONES; INFANT, NEWBORN; INFANT, PREMATURE; OHIO; PREGNANCY; PREMATURE BIRTH; PROGESTINS; RETROSPECTIVE STUDIES;

EID: 84893696366     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000048     Document Type: Article

References (16)

1. Centers for Disease Control and Prevention. Pretermbirth. Available at: http://www.cdc.gov/Reproductivehealth/MaternalInfantHealth/PretermBirth.htm. Retrieved February 2, 2013.
2. March of Dimes. Prematurity project. Available at: http://www. marchofdimes.com/mission/prematurity.html. Retrieved February 2, 2013.
3. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003;348:2379-85.
4. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH; Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007;357:462-9.
5. Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011;38:18-31.
6. de Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double blind study. Am J Obstet Gynecol 2003;188:419-24.
7. Berghella V, Figueroa D, Szychowski JM, Owen J, Hankins G, Iams JD, et al; Vaginal Ultrasound Trial Consortium. 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length. Am J Obstet Gynecol 2010;202: 351.e1-6.
8. Cetingoz E, Cam C, Sakalli M, Karateke A, Celik C, Sancak A. Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial. Arch Gynecol Obstet 2011;283:423-9.
9. Petrini JR, Callaghan WM, Klebanoff M, Green NS, Lackritz EM, Howse JL, et al. Estimated effect of 17-alpha-hydroxyprogesterone caproate on preterm birth in the United States. Obstet Gynecol 2005;105:267-72.
10. Manuck TA, Henry E, Gibson J, Varner MW, Porter TF, Jackson GM, et al. Pregnancy outcomes in a recurrent preterm birth prevention clinic. Am J Obstet Gynecol 2011;204:320. e1-6.
11. Bastek JA, Adamczak JE, Hoffman S, Elovitz MA, Srinivas SK. Trends in prematurity: what do changes at an urban institution suggest about the public health impact of 17-alpha hydroxyprogesterone caproate? Matern Child Health J 2012;16:564-8.
12. Iams JD, Berghella V. Care for women with prior preterm birth. Am J Obstet Gynecol 2010;203:89-100.
13. Multicenter randomized, controlled trial of a preterm birth prevention program. Collaborative Group on Preterm Birth Prevention. Am J Obstet Gynecol 1993;169:352-66.
14. Hobel CJ, Ross MG, Bemis RL, Bragonier JR, Nessim S, Sandhu M, et al. The West Los Angeles Preterm Birth Prevention Project. I. Program impact on high-risk women. Am J Obstet Gynecol 1994;170:54-62.
15. Main DM, Gabbe SG, Richardson D, Strong S. Can preterm deliveries be prevented? Am J Obstet Gynecol 1985;151: 892-8.
16. Mueller-Heubach E, Reddick D, Barnett B, Bente R. Preterm birth prevention: evaluation of a prospective controlled randomized trial. Am J Obstet Gynecol 1989;160:1172-8.